Publication | Closed Access

TRAIL-modified, doxorubicin-embedded periodic mesoporous organosilica nanoparticles for targeted drug delivery and efficient antitumor immunotherapy

NanoparticlesNanomedicineEngineeringPolymer-drug ConjugateMedicineTherapeutic NanomaterialsTargeted Drug DeliveryEfficient Antitumor ImmunotherapyPharmaceutical NanotechnologyNano-drug DeliveryTumor TargetingBiomedical EngineeringImmunotherapyPharmacology